Clinical Trials

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT07217990 2026-02-17

NoCUT-BC

84 enrolled

Phase NA Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07407244 2026-02-17

AKRA

268 enrolled

Breast Neoplasms

NCT05412225 2026-02-11

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Phase 1 Recruiting

60 enrolled

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms

NCT03387553 2026-02-09

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

31 enrolled

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms, Breast Neoplasms, Male

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

34 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06739655 2026-02-04

PRADAIIBE

180 enrolled

Breast Neoplasms, Neoplasms

NCT07383818 2026-02-03

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

111 enrolled

Breast Neoplasms

NCT06498154 2025-12-19

Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy

200 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

35 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT07254858 2025-11-28

CISN-L

302 enrolled

Breast Neoplasms

NCT06611813 2025-08-12

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)

30 enrolled

Breast Neoplasms

NCT06874933 2025-08-12

Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)

35 enrolled

Breast Neoplasms

NCT06914440 2025-07-15

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

27 enrolled

Breast Neoplasms

NCT06977893 2025-05-18

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)

Phase 3 Recruiting

194 enrolled

Breast Neoplasms

NCT05296746 2025-03-18

RIBOLARIS

1,100 enrolled

Breast Neoplasms

NCT05992870 2025-03-17

Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction

40 enrolled

Breast Neoplasms

NCT06447532 2025-03-12

INFLAMMATE

Enrolling by invitation

4,500 enrolled

Breast Neoplasms, Inflammation

NCT06793553 2025-01-30

INDUCE

106 enrolled

Breast Neoplasms

NCT06642428 2025-01-17

Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer

140 enrolled

Phase 2/3 Not yet recruiting

Breast Neoplasms

NCT06769919 2025-01-10

A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer

340 enrolled

Breast Neoplasms

NCT02089100 2024-08-15

STEREO-SEIN

Phase 3 Recruiting

280 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms

NCT06435104 2024-07-09

Aromatherapy in the Treatment of Early Breast Cancer

30 enrolled

Anxiety Disorders, Breast Neoplasms

NCT05216900 2024-06-21

BRENAR

20 enrolled

Breast Neoplasms

NCT06313073 2024-03-15

Neoadjuvant Radiotherapy for Breast Cancer

60 enrolled

Breast Neoplasms

NCT02956473 2024-03-12

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy

Phase NA Completed

57 enrolled 10 charts

Breast Neoplasms

NCT06299930 2024-03-08

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy

Completed

10,328 enrolled

Breast Neoplasms

NCT05912062 2023-09-29

BiOnHER

80 enrolled

Breast Neoplasms, Neoplasms

NCT00665457 2023-09-13

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Phase 2 Terminated

3 enrolled 6 charts

Breast Neoplasms

NCT00881361 2023-04-27

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Phase 2 Completed

756 enrolled 12 charts

Breast Neoplasms

NCT01147016 2023-04-27

Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery

Phase 2 Terminated

8 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT03121989 2023-03-30

LABC

Phase 1 Withdrawn

Breast Neoplasms

NCT05642104 2022-12-08

The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy

175 enrolled

Breast Neoplasms

NCT05479409 2022-07-29

Neoadjuvant Radiation in Locally Advanced Breast Cancer

Phase 2 Unknown

50 enrolled

Breast Neoplasms

NCT03417622 2021-02-25

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Phase 3 Recruiting

370 enrolled

Margins of Excision, Breast Neoplasms

NCT00397761 2021-02-17

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2/3 Withdrawn

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT04249440 2020-09-28

Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer

Completed

1,067 enrolled

Breast Neoplasms

NCT02532400 2020-03-11

COMPETE

Phase 3 Terminated

21 enrolled

Breast Neoplasms

NCT02251353 2020-02-21

IMET

300 enrolled

BreastGastrointestinalHead & Neck

Breast Neoplasms, Neoplasm Metastasis

NCT03323424 2020-01-30

IRAM

Phase 2 Withdrawn

Breast Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT04156841 2019-11-08

Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)

21,000 enrolled

Breast Neoplasms

NCT03520894 2019-10-22

ROCK

Phase NA Unknown

25 enrolled

Breast Neoplasms

NCT01367288 2019-05-28

NEOZOL

Phase 2 Completed

53 enrolled

Breast Neoplasms, Neovascularization, Pathologic

NCT00503841 2019-04-30

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

Phase NA Terminated

44 enrolled 3 charts

Breast Neoplasms

NCT01104571 2018-09-17

EPHOS-B

Phase 3 Unknown

257 enrolled

Breast Neoplasms

NCT00088829 2018-07-11

Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer

Phase 2 Terminated

22 enrolled 3 charts

Breast Neoplasms

NCT00788112 2017-08-07

Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast

Phase 1 Completed

17 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00647218 2017-02-23

Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase NA Completed

38 enrolled

Breast Neoplasms

NCT00491816 2017-01-19

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

Phase 2 Unknown

32 enrolled

Breast Neoplasms, Neoplasms

NCT00379015 2016-09-28

Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer

Phase 2 Completed

38 enrolled